FAKTOR-OPTIONSSCHEIN - AMGEN | Delayed Deutsche Boerse AG 08:34:27 2024-05-23 am EDT | ||
| 2.26 EUR | -1.74% |
|
| Current month | -52.18% | ||
| 1 month | -55.51% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-05-23 | 2.26 | -1.74% |
| 24-05-22 | 2.3 | +6.48% |
| 24-05-21 | 2.16 | -2.70% |
| 24-05-20 | 2.22 | -0.45% |
| 24-05-17 | 2.23 | +3.72% |
Delayed Quote Deutsche Boerse AG
Last update May 23, 2024 at 08:34 am EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
Société Générale
|
| WKN | SQ3K5V |
| ISIN | DE000SQ3K5V2 |
| Date issued | 2022-10-31 |
| Strike | 266.5 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 10.18 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 19.5 € |
|---|---|
| Lowest since issue | 2.06 € |
| Spread | 0.04 € |
| Spread % | 1.72% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
309.4
USD
Average target price
316.1
USD
Spread / Average Target
+2.15%
- Stock Market
- Certificates
- Certificat
